Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: Comparison with 6-[18F]Fluoro-L-Dopa

Journal of Cerebral Blood Flow and Metabolism

Volumn 21, Issue 7, 2001, Pages 782-792

  Poyot, Thomas ^a   Condé, Françoise ^a   Grégoire, Marie Claude ^a   Frouin, Vincent ^a   Coulon, Christine ^a   Fuseau, Chantal ^a   Hinnen, Françoise ^a   Dollé, Frédéric ^a   Hantraye, Philippe ^a   Bottlaender, Michel ^a  

^a DIF   (France)

Author keywords

Baboon; Dopamine transporter; F Dopa; MPTP; PE2I; Striatum

Indexed keywords

6 FLUORODOPA F 18; CARBON 11; DOPAMINE TRANSPORTER; NORTROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE DIAGNOSIS; SUBSTANTIA NIGRA;

EID: 0034958532     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200107000-00003     Document Type: Article

References (44)

1. Performance evaluation of the whole-body PET scanner ECAT EXACT HR+ following the IEC standard
2. Comparison of ketamine with the combination of ketamine and xylazine for effective anesthesia in the rhesus monkey (Macaca mulatta)
3. Quantitative evaluation of a new brain tomograph the ECAT 953B/31
4. 11C]PE2I
5. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
6. Auto-radiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35.428 in the monkey brain
7. Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease
8. 76Br]bromolisuride binding to dopamine D2 receptors studied by PET
9. 11C]flumazenil kinetics studied by PET: Application to a critical study of the equilibrium approaches
10. Quantitation of benzodiazepine receptors in human brain using the partial saturation method
11. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multiinjection approach
12. 18F]Fluoro-L-DOPA by radiofluorodestannylation: A short and simple synthesis of a new labeling precursor
13. 11C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET
14. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4′-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3′,4′- disubstituted phenyl) nortropane. New high-affinity and selective compounds for the dopamine transporter
15. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease
16. Serotonergic sprouting in primate MPTP-induced hemiparkinsonism
17. 11C]-CFT and PET in a primate model of parkinsonism
18. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: Possible neurochemical mechanisms
19. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
20. Comparative nigrostriatal dopaminergic imaging with Iodine-123-Beta CITFP/SPECT and Fluorine-18-FDOPA/PET
21. Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT
22. 18F]GBR 13119 binding to the dopamine uptake site
23. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
24. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
25. Protein measurement with the Folin phenol reagent
26. Multimodality image registration by maximization of mutual information
27. 11C-CFT
28. 18F]Fluoro-L-DOPA
29. N-ω-fluoroalkyl analogs of (1R)-2 β-carbomethoxy-3 β-(4-iodophenyl)-tropane (β-CIT): Radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters
30. 18F]CFT
31. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices
32. Graphical evaluation of blood-to-brain transfer constants multiple-time uptake data. Generalizations
33. An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI and CT brain studies
34. Frontal, mid- brain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [(18)F]dopa-PET study
35. 18F]fluorodopa uptake in five grafted parkinsonian patients
36. Comparison of dopaminergic function and dopamine transporter density at different stages of Parkinson's disease: A PET study
37. 18F]fluorodopa studies correlate with dopamine cell counts and levels
38. Striatal responses to partial dopaminergic lesion: Evidence for compensatory sprouting
39. 18F) fluoro-L Dopa
40. Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain
41. Evaluation of simulation-based scatter correction for 3D PETR cardiac imaging
42. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator
43. Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method
44. Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications